Navigation Links
Gerresheimer Extends Production of Medical Plastic Systems in Bavaria

DUSSELDORF, Germany, December 19, 2011 /PRNewswire/ --


  • Growth in demand for pharmaceutical and medical plastic systems
  • Gerresheimer invests around EUR 25 million in its Pfreimd plant
  • 130 new jobs


Gerresheimer AG, one of the world's leading suppliers to the pharma and healthcare industry, further invests in the growth market of complex plastic systems for pharmaceutical and medical applications. Production capacity is being extended at the southern German production facility in Pfreimd at the value of approximately EUR 25 million. High customer demand led to the decision to among other investment to construct a new production hall where medical plastic systems will be manufactured in clean room environments with state-of-the-art injection moulding machines. As a result of this project around 130 new jobs will be created in Pfreimd.

"There has been a sharp increase in demand for medical delivery systems which are simple and safe for patients to use. These include injection systems, insulin pens and inhalers. We are increasing our production capacity so that we can drive future growth in this market," commented Uwe Röhrhoff, CEO of Gerresheimer AG.

The Plastic Systems division is now one of the company's fastest-growing divisions. Gerresheimer Medical Plastic Systems produces insulin pens for diabetics, inhalers for asthma sufferers, lancing devices and disposable laboratory articles for leading pharma and medical technology companies - from the initial design sketches, through tool making and production to packaging and just-in-time delivery.

Inhalers, diabetic supplies such as insulin pens, lancing devices, lancets and disposable laboratory articles are some of the products manufactured in Pfreimd. The plant currently has 550 employees.

Long version of this press release is available at:

Jens Kürten
Director Corporate Communication & Marketing
Telephone  +49-211-6181-250
Fax  +49-211-6181-241

SOURCE Gerresheimer AG
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Gerresheimer has Passed the Turning Point
2. Gerresheimer Achieves Sales Target for 2009
3. Moodys Raised Outlook for Gerresheimer
4. Substantial Revenues and Earnings Plus for Gerresheimer
5. Gerresheimer Reports Strong Earnings and Sales Growth
6. Gerresheimer Reports Strong Revenues and Earnings Growth in the Second Quarter
7. Vidaza Significantly Extends Overall Survival by 74% in Phase 3 Trial in Myelodysplastic Syndromes (MDS)
8. Quark Pharmaceuticals Extends Research Agreement with State University of New York for Proprietary siRNA Compounds for Acute Hearing Loss
9. Baxa Corporation Extends Global Reach With New Distribution Agreements in Colombia and the Dominican Republic
10. FDA Extends Review of Genasense(R) NDA Appeal in Chronic Lymphocytic Leukemia
11. Protalix BioTherapeutics Extends Research Agreement With Yissum Based on Promising Acetylcholinesterase Program Results in Animal Study
Post Your Comments:
(Date:6/23/2016)... INDIANAPOLIS , June 23, 2016 Roche ... received 510(k) clearance for its Elecsys BRAHMS PCT (procalcitonin) ... severe sepsis or septic shock. With this clearance, Roche ... provide a fully integrated solution for sepsis risk assessment ... associated with bacterial infection and PCT levels in blood ...
(Date:6/23/2016)... -- Research and Markets has announced the addition ... to their offering. The ... commercial environment for MedImmune to enter. The US ageing population ... to drive considerable growth for effective anti-influenza medications. The introduction ... considerably, but development is still in its infancy. ...
(Date:6/23/2016)... INDIANAPOLIS , June 23, 2016 If ... Leaders Scholarship is any indication, the future is in ... at by the Diabetes Scholars Foundation ... the way of academic and community service excellence. ... since 2012, and continues to advocate for people with ...
Breaking Medicine Technology:
(Date:6/25/2016)... Beach, CA (PRWEB) , ... June 25, 2016 , ... ... UCLA with Magna Cum Laude and his M.D from the David Geffen School of ... Diego and returned to Los Angeles to complete his fellowship in hematology/oncology at the ...
(Date:6/25/2016)... ... 25, 2016 , ... On Friday, June 10, Van Mitchell, Secretary of the ... to iHire in recognition of their exemplary accomplishments in worksite health promotion. , The ... Health & Wellness Symposium at the BWI Marriott in Linthicum Heights. iHire was one ...
(Date:6/24/2016)... , ... June 24, 2016 , ... A recent ... most people are unfamiliar with. The article goes on to state that individuals are ... many of these less common operations such as calf and cheek reduction. The Los ...
(Date:6/24/2016)... ... June 24, 2016 , ... June 19, 2016 is World Sickle Cell Observance ... and the benefits of holistic treatments, Serenity Recovery Center of Marne, Michigan, ... Disease. , Sickle Cell Disease (SCD) is a disorder of the red blood cells, ...
(Date:6/24/2016)... Texas (PRWEB) , ... June 24, 2016 , ... ... International Conference and Scientific Sessions in Dallas that it will receive two significant ... of the grants came as PHA marked its 25th anniversary by recognizing patients, ...
Breaking Medicine News(10 mins):